Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
State Street Corp reported a 5.10% stake in Arcutis Biotherapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 12, 2026
State Street Corp reported a 5.10% stake in Arcutis Biotherapeutics, Inc., 6,296,197 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 6,296,197
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.10% | 6,296,197 |
Source
Related
- Arcutis Biotherapeutics, Inc.
- State Street Corp
- Arcutis Biotherapeutics, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Welgus Howard G. · Oct 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 5, 2026
- Form 4 · Matsuda Masaru · Sep 18, 2026
- Form 4 · Welgus Howard G. · Sep 17, 2026
- Form 4 · Matsuda Masaru · Sep 10, 2026